Abstract:Gang Gui, 1, * Ziqi Fan, 1, * Yihuan Ning, 1 Cancan Yuan, 2 Baolin Zhang, 3 Qin Xu 1 1 College of Pharmacy, Guilin Medical University, Guilin, 541004, People's Republic of China; 2 Department of Pharmacy, Luohe City People's Hospital, Luohe, 462000, People's Republic of China; 3 College of Materials Science and Engineering, Guilin University of Technology, Guilin, 541004, People's Republic of China *These authors contributed equally to this work Correspondence: Qin Xu College of Pharmacy, Guilin Medical University, Guilin, 541004, People's Republic of China Email xuqincpu@126.com Baolin Zhang College of Materials Science and Engineering, Guilin University of Technology, Guilin, 541004, People's Republic of China Email zhangbaolin@glut.edu.cn Background: Paclitaxel (PTX) has interesting anticancer activity. However, it is insoluble in water, which seriously hinders its use in clinical. Superparamagnetic iron oxide nanoparticles (SPIONs) are used as an ideal drug delivery system. Therefore, we proposed a folic acid (FA) targeting drug-loaded SPIONs to reduce its adverse reaction. Methods: To improve the hydrophilicity of PTX, the structure of PTX was modified by succinic anhydride to obtain 2ʹ-succinate paclitaxel (SPTX). FA conjugated Polyethylene glycol (PEG)/polyethyleneimine (PEI)-SPIONs SPTX-loaded nanoparticles (SPTX@FA@PEG/PEI-SPIONs) were prepared by solvent volatilization and hydrogen bond adsorption, and the nano-formulation was optimized by response surface methodology (RSM). The characteristics, antitumor effect in vitro, pharmacokinetics, and biodistribution of SPTX@FA@PEG/PEI-SPIONs were evaluated. Results: SPTX was successfully loaded on the surface of FA@PEG/PEI-SPIONs. The formation of SPTX@FA@PEG/PEI-SPIONs was exhibited water-dispersive monodispersity with high stability by RSM, and dynamic light scattering (DLS) was 178.1± 3.12 nm, particle size observed in the transmission electron microscope (TEM) was 13.01± 1.10 nm, and the encapsulation efficiency (EE) and loading efficiency (LE) were 81.1± 1.66% and 14.8± 1.46%, respectively. It enhanced the stability in normal physiological condition, accelerated drug release at tumorous pH, and preferentially prolonged the circulation time. In vitro, the SPTX@FA@PEG/PEI-SPIONs significantly targeted to folate receptor (FR) positive cancers cell (HNE-1) via the receptor-ligand mediated pathway, resulting in effective cytotoxic activity. Pharmacokinetic results demonstrated that SPTX@FA@PEG/PEI-SPIONs (t 1/2 =3.41 h) had longer than free SPTX or PTX (t 1/2 =1.67 h) in rats in vivo. Tissue distribution studies showed that SPTX@FA@PEG/PEI-SPIONs were present at high levels in the liver and help in targeting the folate receptors present on the kidneys. Conclusion: These results suggest that SPTX@FA@PEG/PEI-SPIONs offer a highly promising approach to control drug release, improve drug pharmacokinetics and actively target the nasopharyngeal carcinoma. Keywords: paclitaxel, folic acid, superparamagnetic iron oxide nanoparticles, targeted drug delivery, response surface methodology, anti-nasopharyngeal carcinoma

The Theranostic Efficiency of Tumor-Specific, Ph-Responsive, Peptide-Modified, Liposome-Containing Paclitaxel and Superparamagnetic Iron Oxide Nanoparticles

Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles

The Efficiency of Tumor-Specific Ph-Responsive Peptide-Modified Polymeric Micelles Containing Paclitaxel.

Platelet Membrane-Coated SPION for Targeted Paclitaxel Delivery and Magnetic Hyperthermia in Cancer Therapy

Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis

Conjugation of Paclitaxel to Iron Oxide Nanoparticles for Tumor Imaging and Therapy

GE11-PDA-Pt@USPIOs Nano-Formulation for Relief of Tumor Hypoxia and MRI/PAI-guided Tumor Radio-Chemotherapy

Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics As a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy

pH-Responsive Tumor-Targetable Theranostic Nanovectors Based on Core Crosslinked (CCL) Micelles with Fluorescence and Magnetic Resonance (MR) Dual Imaging Modalities and Drug Delivery Performance

Tumor Cell Membrane-Based Peptide Delivery System Targeting to Tumor Microenvironment for Cancer Immunotherapy and Diagnosis

A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug

Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics

C2nr11918h 2306..2310

Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles

Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.

Human serum albumin and sialic acid co-modified liposome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy

Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment

Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide

Ultralong tumor retention of theranostic nanoparticles with short peptide-enabled active tumor homing

Multi-Stimuli-Responsive DOX Released from Magnetosome for Tumor Synergistic Theranostics

Erythrocyte Membrane-Wrapped Ph Sensitive Polymeric Nanoparticles for Non-Small Cell Lung Cancer Therapy.